Stocks Overview

LAST PRICE
27.2200
TODAY'S CHANGE (%)
Trending Down-1.4600 (-5.0907%)

Bid / Lots
26.3100/ 1
Ask / Lots
29.2300/ 1
Open / Previous Close
28.5400 / 28.6800
Day Range
Low 27.2200
High 28.5400
52 Week Range
Low 27.2200
High 51.2200
Volume
329,302
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 28.68
Time	Volume	SLP
09:32 ET	470	28.54
09:39 ET	800	28.44
09:45 ET	400	28.385
09:52 ET	150	28.25
09:54 ET	375	28.233
09:56 ET	1169	28.22
10:03 ET	260	28.25
10:10 ET	1100	28.09
10:12 ET	200	28.085
10:15 ET	300	28.045
10:17 ET	1566	28.095
10:19 ET	100	28.135
10:21 ET	2000	28.135
10:24 ET	100	28.08
10:26 ET	1064	28.08
10:28 ET	200	28.07
10:30 ET	2000	28.05
10:32 ET	600	28.04
10:33 ET	175	28.076
10:39 ET	2494	28.08
10:44 ET	1662	28.01
10:46 ET	2156	27.98
10:51 ET	995	27.92
11:00 ET	991	27.9
11:04 ET	8527	28.03
11:15 ET	2900	27.9946
11:18 ET	100	27.98
11:22 ET	264	28.0326
11:24 ET	998	28.0038
11:26 ET	1200	28.06
11:27 ET	605	27.985
11:33 ET	8228	27.865
11:38 ET	9932	27.95
11:40 ET	100	27.95
11:42 ET	1037	27.9
11:44 ET	500	27.915
11:45 ET	1500	27.945
11:49 ET	100	27.95
11:51 ET	200	27.94
11:54 ET	200	27.93
11:56 ET	600	27.92
12:03 ET	521	27.93
12:07 ET	315	27.93
12:12 ET	2531	27.93
12:14 ET	3433	27.94
12:25 ET	1521	27.92
12:36 ET	1200	27.85
12:39 ET	3949	27.86
12:41 ET	3023	27.81
12:45 ET	100	27.78
12:48 ET	703	27.82
12:50 ET	100	27.855
12:54 ET	1167	27.84
12:56 ET	446	27.89
12:59 ET	2028	27.84
01:03 ET	1200	27.81
01:06 ET	949	27.77
01:08 ET	1605	27.8
01:12 ET	7428	27.855
01:15 ET	112	27.82
01:17 ET	103	27.83
01:21 ET	1188	27.81
01:24 ET	200	27.815
01:26 ET	6768	27.845
01:28 ET	100	27.85
01:30 ET	100	27.83
01:33 ET	300	27.82
01:35 ET	100	27.79
01:37 ET	200	27.78
01:44 ET	500	27.7
01:48 ET	662	27.65
01:50 ET	300	27.645
01:51 ET	4872	27.7
01:53 ET	500	27.71
01:55 ET	800	27.76
01:57 ET	483	27.765
02:00 ET	210	27.75
02:02 ET	100	27.72
02:04 ET	800	27.68
02:06 ET	2210	27.67
02:15 ET	200	27.64
02:18 ET	400	27.635
02:20 ET	1999	27.73
02:22 ET	600	27.77
02:24 ET	905	27.81
02:26 ET	400	27.87
02:27 ET	300	27.82
02:29 ET	600	27.815
02:36 ET	450	27.79
02:38 ET	3551	27.82
02:44 ET	500	27.82
02:45 ET	691	27.77
02:47 ET	700	27.74
02:49 ET	1200	27.775
02:56 ET	355	27.75
02:58 ET	200	27.765
03:00 ET	4689	27.705
03:02 ET	702	27.72
03:03 ET	500	27.71
03:05 ET	100	27.72
03:07 ET	800	27.73
03:09 ET	1789	27.77
03:12 ET	200	27.745
03:14 ET	900	27.74
03:16 ET	2829	27.7
03:20 ET	1000	27.67
03:21 ET	2190	27.705
03:23 ET	400	27.66
03:27 ET	3675	27.625
03:32 ET	537	27.59
03:34 ET	600	27.58
03:36 ET	3295	27.63
03:38 ET	1610	27.665
03:39 ET	100	27.65
03:41 ET	1026	27.63
03:43 ET	3226	27.61
03:45 ET	1291	27.575
03:48 ET	1760	27.52
03:50 ET	500	27.52
03:52 ET	3405	27.49
03:54 ET	3182	27.47
03:56 ET	4982	27.42
03:57 ET	5926	27.35
03:59 ET	46169	27.22

Data delayed at least 15 minutes.

Yesterday
- Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations, from 8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 24, 2024
- DJ Simulations Plus Is Maintained at Buy by BTIG, from 12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
  12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 23, 2024
- *DJ Simulations Plus 4Q EPS 4c >SLP, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
  4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
- Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
  4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 9, 2024
- Press Release: Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date, from 5:49PM ET on Wednesday Oct 09, 2024 by Dow Jones
  5:49PM ET on Wednesday Oct 09, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSLP Simulations Plus Inc	573.8M	57.4x	+3.18%
United StatesIRMD IRadimed Corp	670.7M	33.7x	+21.02%
United StatesBFLY Butterfly Network Inc	391.1M	-3.4x	---
United StatesMXCT MaxCyte Inc	372.8M	-10.5x	---
United StatesLAB Standard BioTools Inc	697.8M	-2.2x	---
United StatesNPCE Neuropace Inc	202.3M	-5.9x	---
As of 2024-10-31

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. The Company also provides tech-enabled training and compliance solutions for clinical trial investigators and site staff.

Contact Information

Headquarters: 42505 10Th Street WestLANCASTER, CA, United States 93534-7059
Phone: 661-723-7723
Fax: 661-723-5524

Executives

Chairman of the Board: Walter Woltosz
Chief Executive Officer: Shawn O'Connor
Chief Financial Officer, Chief Operating Officer, Secretary: William Frederick
President - PBPK, Regulatory Strategies, Cheminformatics Solutions: John Dibella
President - Clinical Pharmacology and Pharmacometric Services: Jill Fiedler-Kelly

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$573.8M
Revenue (TTM)	$67.0M
Shares Outstanding	20.0M
Dividend Yield	0.88%
Annual Dividend Rate	0.2400 USD
Ex-Dividend Date	07-29-24
Pay Date	08-05-24
Beta	0.69
EPS	$0.47
Book Value	$8.53
P/E Ratio	57.4x
Price/Sales (TTM)	8.6
Price/Cash Flow (TTM)	40.6x
Operating Margin	9.83%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Simulations Plus Inc
NASDAQ:SLPUnited States

Search Criteria

Charts

Recent News

Yesterday

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations, from 8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

Oct 24, 2024

DJ Simulations Plus Is Maintained at Buy by BTIG, from 12:26PM ET on Thursday Oct 24, 2024 by Dow Jones

Oct 23, 2024

*DJ Simulations Plus 4Q EPS 4c >SLP, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones

Oct 9, 2024

Press Release: Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date, from 5:49PM ET on Wednesday Oct 09, 2024 by Dow Jones

Advanced Medical Equipment Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar